Rexahn Pharmaceuticals Inc (RNN) - NYSEMKT
Company Description
Rexahn Pharmaceuticals, Inc. is a development stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer and other medical needs. The company currently has three clinical stage oncology candidates, Archexin, RX-3117, and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States